Free Trial

HCW Biologics (HCWB) SEC Filings & 10K Form

HCW Biologics logo
$5.22 -0.27 (-4.92%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$5.52 +0.30 (+5.77%)
As of 08:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent HCW Biologics SEC Filings

DateFilerForm TypeView
06/05/2025
7:30 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
7:30 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
9:27 AM
HCW Biologics (Filer)
Form 424B4
05/14/2025
11:15 PM
HCW Biologics (Filer)
Form EFFECT
05/13/2025
3:18 PM
HCW Biologics (Filer)
Form S-1/A
05/09/2025
4:28 PM
Greene Rick S. (Reporting)
HCW Biologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:29 PM
Flowers Lee (Reporting)
HCW Biologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:30 PM
Byam Rebecca (Reporting)
HCW Biologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:31 PM
GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:32 PM
HCW Biologics (Issuer)
Wong Hing C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:33 PM
HCW Biologics (Issuer)
Winer Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
12:55 PM
HCW Biologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/28/2025
8:17 AM
HCW Biologics (Filer)
Form DEF 14A
04/28/2025
7:45 AM
HCW Biologics (Filer)
Form DEFA14A
04/28/2025
7:50 AM
HCW Biologics (Filer)
Form ARS
04/22/2025
4:15 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
11:15 PM
HCW Biologics (Filer)
Form EFFECT
04/16/2025
3:26 PM
HCW Biologics (Filer)
Form 424B3
04/07/2025
5:06 AM
HCW Biologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/01/2025
3:40 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
3:30 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
2:40 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
2:45 PM
HCW Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
4:00 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
6:00 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:25 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:29 PM
HCW Biologics (Filer)
Form DEF 14A
02/11/2025
3:54 PM
HCW Biologics (Filer)
Form PRE 14A
02/07/2025
3:45 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
6:30 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
7:30 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:37 PM
HCW Biologics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/22/2024
3:53 PM
HCW Biologics (Subject)
Wong Hing C (Filed by)
Form SC 13D/A
11/22/2024
3:45 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
11:54 AM
HCW Biologics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
11/18/2024
6:00 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
4:25 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:35 PM
HCW Biologics (Filer)
Form 8-K/A
08/14/2024
3:45 PM
HCW Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
3:40 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:35 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
[No Brainer Gold Play]: “Show me a better investment.” (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
07/18/2024
6:00 AM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:30 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
3:56 PM
HCW Biologics (Issuer)
Winer Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:57 PM
Greene Rick S. (Reporting)
HCW Biologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:33 PM
HCW Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HCWB) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners